234 related articles for article (PubMed ID: 26775694)
21. Transcriptional CDK inhibitors, CYC065 and THZ1 promote Bim-dependent apoptosis in primary and recurrent GBM through cell cycle arrest and Mcl-1 downregulation.
Juric V; Hudson L; Fay J; Richards CE; Jahns H; Verreault M; Bielle F; Idbaih A; Lamfers MLM; Hopkins AM; Rehm M; Murphy BM
Cell Death Dis; 2021 Aug; 12(8):763. PubMed ID: 34344865
[TBL] [Abstract][Full Text] [Related]
22. Mcl-1 targeting could be an intriguing perspective to cure cancer.
De Blasio A; Vento R; Di Fiore R
J Cell Physiol; 2018 Nov; 233(11):8482-8498. PubMed ID: 29797573
[TBL] [Abstract][Full Text] [Related]
23. ELK4 neutralization sensitizes glioblastoma to apoptosis through downregulation of the anti-apoptotic protein Mcl-1.
Day BW; Stringer BW; Spanevello MD; Charmsaz S; Jamieson PR; Ensbey KS; Carter JC; Cox JM; Ellis VJ; Brown CL; Walker DG; Inglis PL; Allan S; Reynolds BA; Lickliter JD; Boyd AW
Neuro Oncol; 2011 Nov; 13(11):1202-12. PubMed ID: 21846680
[TBL] [Abstract][Full Text] [Related]
24. Usp9x Promotes Survival in Human Pancreatic Cancer and Its Inhibition Suppresses Pancreatic Ductal Adenocarcinoma In Vivo Tumor Growth.
Pal A; Dziubinski M; Di Magliano MP; Simeone DM; Owens S; Thomas D; Peterson L; Potu H; Talpaz M; Donato NJ
Neoplasia; 2018 Feb; 20(2):152-164. PubMed ID: 29248719
[TBL] [Abstract][Full Text] [Related]
25. Ionizing radiation sensitizes breast cancer cells to Bcl-2 inhibitor, ABT-737, through regulating Mcl-1.
Wu H; Schiff DS; Lin Y; Neboori HJ; Goyal S; Feng Z; Haffty BG
Radiat Res; 2014 Dec; 182(6):618-25. PubMed ID: 25409124
[TBL] [Abstract][Full Text] [Related]
26. Aberrant expression of deubiquitylating enzyme USP9X predicts poor prognosis in gastric cancer.
Fu X; Xie W; Song X; Wu K; Xiao L; Liu Y; Zhang L
Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):687-692. PubMed ID: 28274596
[TBL] [Abstract][Full Text] [Related]
27. USP9X deubiquitinates ALDH1A3 and maintains mesenchymal identity in glioblastoma stem cells.
Chen Z; Wang HW; Wang S; Fan L; Feng S; Cai X; Peng C; Wu X; Lu J; Chen D; Chen Y; Wu W; Lu D; Liu N; You Y; Wang H
J Clin Invest; 2019 Apr; 129(5):2043-2055. PubMed ID: 30958800
[TBL] [Abstract][Full Text] [Related]
28. USP9X stabilizes BRCA1 and confers resistance to DNA-damaging agents in human cancer cells.
Lu Q; Zhang FL; Lu DY; Shao ZM; Li DQ
Cancer Med; 2019 Nov; 8(15):6730-6740. PubMed ID: 31512408
[TBL] [Abstract][Full Text] [Related]
29. Beclin 1 restrains tumorigenesis through Mcl-1 destabilization in an autophagy-independent reciprocal manner.
Elgendy M; Ciro M; Abdel-Aziz AK; Belmonte G; Dal Zuffo R; Mercurio C; Miracco C; Lanfrancone L; Foiani M; Minucci S
Nat Commun; 2014 Dec; 5():5637. PubMed ID: 25472497
[TBL] [Abstract][Full Text] [Related]
30. Mcl-1 antagonism is a potential therapeutic strategy in a subset of solid cancers.
Modugno M; Banfi P; Gasparri F; Borzilleri R; Carter P; Cornelius L; Gottardis M; Lee V; Mapelli C; Naglich JG; Tebben A; Vite G; Pastori W; Albanese C; Corti E; Ballinari D; Galvani A
Exp Cell Res; 2015 Mar; 332(2):267-77. PubMed ID: 25486070
[TBL] [Abstract][Full Text] [Related]
31. Sec6/8 regulates Bcl-2 and Mcl-1, but not Bcl-xl, in malignant peripheral nerve sheath tumor cells.
Tanaka T; Kikuchi N; Goto K; Iino M
Apoptosis; 2016 May; 21(5):594-608. PubMed ID: 26892009
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of the deubiquitinase USP9x induces pre-B cell homeobox 1 (PBX1) degradation and thereby stimulates prostate cancer cell apoptosis.
Liu Y; Xu X; Lin P; He Y; Zhang Y; Cao B; Zhang Z; Sethi G; Liu J; Zhou X; Mao X
J Biol Chem; 2019 Mar; 294(12):4572-4582. PubMed ID: 30718275
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of deubiquitinases primes glioblastoma cells to apoptosis in vitro and in vivo.
Karpel-Massler G; Banu MA; Shu C; Halatsch ME; Westhoff MA; Bruce JN; Canoll P; Siegelin MD
Oncotarget; 2016 Mar; 7(11):12791-805. PubMed ID: 26872380
[TBL] [Abstract][Full Text] [Related]
34. MCL-1 Is a Key Antiapoptotic Protein in Human and Rodent Pancreatic β-Cells.
Meyerovich K; Violato NM; Fukaya M; Dirix V; Pachera N; Marselli L; Marchetti P; Strasser A; Eizirik DL; Cardozo AK
Diabetes; 2017 Sep; 66(9):2446-2458. PubMed ID: 28667119
[TBL] [Abstract][Full Text] [Related]
35. Targeting Mcl-1 for multiple myeloma (MM) therapy: drug-induced generation of Mcl-1 fragment Mcl-1(128-350) triggers MM cell death via c-Jun upregulation.
Fan F; Tonon G; Bashari MH; Vallet S; Antonini E; Goldschmidt H; Schulze-Bergkamen H; Opferman JT; Sattler M; Anderson KC; Jäger D; Podar K
Cancer Lett; 2014 Feb; 343(2):286-94. PubMed ID: 24120758
[TBL] [Abstract][Full Text] [Related]
36. KRIBB11 accelerates Mcl-1 degradation through an HSF1-independent, Mule-dependent pathway in A549 non-small cell lung cancer cells.
Kang MJ; Yun HH; Lee JH
Biochem Biophys Res Commun; 2017 Oct; 492(3):304-309. PubMed ID: 28859986
[TBL] [Abstract][Full Text] [Related]
37. Adenovirus-mediated transfer of siRNA against basic fibroblast growth factor mRNA enhances the sensitivity of glioblastoma cells to chemotherapy.
Feng X; Zhang B; Wang J; Xu X; Lin N; Liu H
Med Oncol; 2011 Mar; 28(1):24-30. PubMed ID: 20221717
[TBL] [Abstract][Full Text] [Related]
38. Somatic mutations in myeloid cell leukemia-1 contribute to the pathogenesis of glioma by prolonging its half-life.
Lv X; Tan G; Yao Y; Lv L; Deng X; Dong L; Li S; Li L; Xu Y
Mol Med Rep; 2015 Jul; 12(1):1265-71. PubMed ID: 25777305
[TBL] [Abstract][Full Text] [Related]
39. RAD18 mediates resistance to ionizing radiation in human glioma cells.
Xie C; Wang H; Cheng H; Li J; Wang Z; Yue W
Biochem Biophys Res Commun; 2014 Feb; 445(1):263-8. PubMed ID: 24518219
[TBL] [Abstract][Full Text] [Related]
40. KRIBB11 Induces Apoptosis in A172 Glioblastoma Cells via MULE-Dependent Degradation of MCL-1.
Yoo K; Yun HH; Jung SY; Lee JH
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
